Interim / Quarterly Report • Aug 14, 2025
Interim / Quarterly Report
Open in ViewerOpens in native device viewer

Half Year Report & Financial Statements for the six months ended 30th June 2025

| Investment Objective and Benchmark |
Key Investment Policies | Gearing Policy |
|---|---|---|
| To achieve capital growth from North American investments by outperformance of the Company's benchmark, which is the S&P 500 Index, with net dividends reinvested, expressed in sterling terms. |
To invest in North American quoted companies including, when appropriate, exposure to smaller capitalisation companies. To emphasise capital growth rather than income. |
The Company's gearing policy is to operate within a range of 5% net cash to 20% geared in normal market conditions. Within this range, the Board reviews and sets a strategic gearing level, which is currently 10% + or – 2%. The current tactical level of gearing is 5% with a permitted range around this level of + or – 5%, meaning that currently gearing can vary between 0% and 10%. |
| Risk | Management Fees | Management Company |
| As at 30th June 2025, the Company's share capital comprised 281,633,910 ordinary shares of 5p each, including 104,527,250 shares held in Treasury. |
The management fee is charged on a tiered basis as follows: • 0.35% on the first £500 million of net assets; • 0.30% on net assets above £500 million and up to £1 billion; and • 0.25% on any net assets above £1 billion. |
The Company employs JPMorgan Funds Limited ('JPMF' or the 'Manager' or the 'Investment Manager') as its Alternative Investment Fund Manager. JPMF delegates the management of the Company's portfolio to JPMorgan Asset Management (UK) Limited ('JPMAM') which further delegates the management to JPMorgan Investment Management, Inc. All of these entities are wholly owned subsidiaries of J.P. Morgan Chase & Co. |
The Company's website, www.jpmamerican.co.uk provides useful information such as daily prices, factsheets and current and historic half year and annual reports.
The Company is a member of the AIC.
Sign up to receive regular email updates on the Company's progress. Our quarterly newsletter delivers topical and relevant news and views directly to your inbox. Scan this QR code on your smartphone camera or opt in via https://web.gim.jpmorgan.com/emea_investment_trust_subscription/welcome?targetFund=JAM to receive regular updates on JPMorgan American Investment Trust plc.

General enquiries about the Company should be directed to the Company Secretary at [email protected]
| FINANCIAL CALENDAR | |
|---|---|
| Financial year end | 31st December |
| Final results announced | March/April |
| Annual General Meeting | May |
| Half year end | 30th June |
| Half year results announced | August |
| Dividend on ordinary shares paid | May/October |
Launched in 1881, the award-winning JPMorgan American Investment Trust plc ('JAM' or the 'Company') seeks to achieve capital growth from North American investments by outperformance of the Company's benchmark, which is the S&P 500 Index, with net dividends reinvested, expressed in sterling terms. Managed by four experienced Portfolio Managers, supported by an extensive network of US based research analysts and investment specialists, the Company aims to deliver its investment objective and provide highly actively managed exposure to the US stock market by investing in the most attractive value and growth stocks identified by our two specialist investment teams.

The investment approach is a collaborative effort between the four Portfolio Managers. In order to build a concentrated portfolio of stocks, the team follows a rigorous in-depth research process that involves more than 900 company meetings each year. They use a checklist of 40+ questions to establish a company's key risks and classify it in terms of quality, as well as looking at financial metrics such as earnings growth and dividends to assess whether it is valued at a price they are willing to pay.

By blending value and growth investing, the Portfolio Managers create a high-conviction, unique 40-stock Large Cap portfolio designed to perform well across various market conditions. This represents 90% or more of the company's total portfolio and combines the Manager's top growth and value ideas. Additionally, up to 10% is allocated to a Small Cap Portfolio, targeting smaller market cap companies.

The Investment Trust structure offers several advantages including:

The Manager developed their own standards for ESG analysis, rather than relying on scores decided by an outside agency. This framework enables the teams to identify the financially material ESG risks and opportunities in each sector, score companies against the most relevant factors for their sub-industry, and then actively engage with managements to help them address areas of weakness.

Whilst capital growth is the primary aim of the Company, an interim dividend of 2.75p per share has been proposed for 2025. A total dividend of 11.00p per share was paid in respect of FY24, a 41.9% increase on the prior year's total dividend of 7.75p per share.
A low Ongoing Charges Ratio (OCR) of 0.34% makes the Company one of the most competitively priced US actively managed funds available to UK investors, in either closed-ended or open-ended form.

JAM has been recognised over the years with many investment awards and ratings. Notably, the 2024 North America Equities Citywire Award, 2025 AIC ISA Millionaire Award along with recommendations from Kepler Growth amongst others in 2025. Routine press coverage from respected publications such as Investors Chronicle, Shares, and MoneyWeek is a testament to the long-term performance record, hard work and dedication of the entire team.
| Half Year Performance | |
|---|---|
| Financial Highlights | 6 |
| Chair's Statement | |
| Chair's Statement | 9 |
| Investment Review | |
| Investment Manager's Report | 13 |
| Portfolio Information | 19 |
| List of Investments | 20 |
| Financial Statements | |
| Condensed Statement of Comprehensive Income | 22 |
| Condensed Statement of Changes in Equity | 23 |
| Condensed Statement of Financial Position | 24 |
| Condensed Statement of Cash Flows | 25 |
| Notes to the Condensed Financial Statements | 26 |
| Interim Management Report | |
| Interim Management Report | 30 |
| Shareholder information | |
| Glossary of Terms | 32 |
| Alternative Performance Measures ('APMs') | 33 |
| Investing in JPMorgan American Investment Trust plc | 36 |
| Share Fraud Warning | 37 |
| Information About the Company | 38 |

Image: The South Congress bridge in Austin, Texas, US

1 Source: Morningstar.
2 Source: Morningstar/J.P. Morgan, using cum income net asset value per share.
3 The Company's benchmark index is the S&P 500 Index, net of the appropriate withholding tax, expressed in sterling total return terms.
4 Annualised returns calculated on a geometric basis for periods greater than one year. Six month returns are not annualised.
APM Alternative Performance Measure ('APM').
Glossary of Terms and Alternative Performance Measures are provided on page 32.
| Net asset value, share price, discount and market data | 30th June 2025 |
31st December 2024 |
% change |
|---|---|---|---|
| Net asset value per share with: | |||
| – debt at fair value1, APM | 1,054.4p | 1,115.7p | –5.5 |
| – debt at par valueAPM | 1,050.4p | 1,109.9p | –5.4 |
| S&P 500 Index expressed in sterling (capital only)2 | 4,528.0 | 4,696.3 | –3.6 |
| Share price | 1,022.0p | 1,130.0p | –9.6 |
| Share price (discount)/premium to net asset value per share with: | |||
| – debt at fair valueAPM | (3.1)% | 1.3% | |
| – debt at par valueAPM | (2.7)% | 1.8% | |
| Market capitalisation (£'000) | 1,810,030 | 2,023,784 | –10.6 |
| Exchange rate | 1 = 1.3704 £ \$ |
1 = 1.2524 £ \$ |
–8.63 |
| Shareholders' funds (£'000) | 1,860,243 | 1,987,845 | –6.4 |
| Shares in issue (excluding shares held in Treasury)4 | 177,106,660 | 179,095,954 | –1.1 |
| GearingAPM | 4.9% | 2.8% | |
| Ongoing charges ratioAPM | 0.34% | 0.35% |
The percentage changes in net asset value per share and share price, as shown in the table above, represent the returns achieved after dividends have been distributed for the period. The percentage changes for the total returns, which assume dividends paid out by the Company are reinvested, are shown on page 6.
1 The fair value of the combined US\$100m private placements issued by the Company was calculated using discounted cash flow technique, using the yield from a similarly dated treasury note plus a margin based on the US Broad Market AA 10-15 year spread.
2 Source: Datastream.
3 The % change in the exchange rate is based on the weakening of the US dollar against Sterling during the period.
4 Excluding 104,527,250 (31st December 2024: 102,537,956) shares held in Treasury.
APM Alternative Performance Measure ('APM').
Glossary of Terms and Alternative Performance Measures are provided on page 32.
The first six months of 2025 were marked by volatility in the US stock market, driven by geopolitical tensions and fluctuating economic indicators. Despite some initial optimism following the new US administration's economic policy announcements, concerns over potential trade conflicts only added to market uncertainty, which peaked in early April. The Federal Reserve's cautious approach to interest rate adjustments given inflation remaining above target also weighed on market sentiment. Despite these challenges, some companies managed to report positive earnings growth, which helped to lift markets back to near record levels at the end of the period.
Against this backdrop, GBP returns for both the Company and the Company's index were negative reflecting the impact of the US dollar's weakest first half performance since 1973. The Company's total return on net assets per share over the six months to end June 2025 was –4.6% in GBP terms, underperforming the –3.0% GBP total return on the Company's benchmark, the S&P 500 Index, by –1.6 percentage points on a net asset value per share ('NAV') basis. The GBP return on share price was –8.7%, reflecting a widening of the Company's discount to NAV over the period.
The large-cap component of the Company adopts a higher-conviction approach combining the best ideas from the Manager's growth and value investment teams. In the six years since this approach was adopted in June 2019, the Company has outperformed the benchmark index by +20.4% in the subsequent 73 months through to the end of June 2025, providing a NAV total return to shareholders of +145.6%, compared with a benchmark return of +125.2%. This represents an annualised outperformance of +1.6 percentage points over the six-year period.
At the end of the review period, 94.5% of your Company's portfolio assets were invested in US large cap stocks, in a high conviction portfolio of 39 stocks. This represents a carefully curated selection of the Manager's best growth and value investment ideas. The proportions of growth and value weightings can vary between 60% and 40% in either direction and stood at 56% in growth stocks and 44% in value names at the period end. The overall allocation to the small cap portfolio was 5.5% at the end of the review period.
More details about performance attribution and portfolio activity during the half-year can be found in the Investment Manager's report on pages 13 to 18, along with their view on the outlook for US equity markets.
As previously reported, Jonathan Simon retired as the portfolio manager responsible for value stocks in the Company's large cap portfolio on 3rd March 2025. The portfolio's value stocks are now managed by Jack Caffrey and Graham Spence, while the growth stocks continue to be managed by Felise Agranoff and Eric Ghernati.
There are no changes to the Company's investment process or investment objective as a result of these changes.
The Company's shares have traded at an average discount during the period under review of 2.0% relative to NAV. The Company has continued to both buy back and issue shares in line with the Board's longstanding position of buying back shares when they stand at anything more than a small discount to NAV, and issuing shares when they are trading at a premium to NAV at least sufficient to cover the costs of issuance.

Robert Talbut Chair
The Company bought into Treasury a total of 3,403,340 shares, or 1.9% of the Company's issued share capital during the six months to end June 2025, excluding shares held in treasury (30th June 2024: 0.8%). These shares were purchased at an average discount to NAV of 3.1%, producing a modest accretion to the NAV for continuing shareholders. The Company issued a total of 1,414,046 shares from treasury during the same period, at an average premium to NAV of 0.8%.
The Company is declaring a dividend of 2.75 pence per share (2024: 2.75 pence) for the first six months of this year, which will be payable on 6th October 2025 to shareholders on the register on 29th August 2025. While capital growth is the primary aim of the Company, the Board understands that dividend receipts can be an important element of shareholder returns. The Board continues to monitor the net income position of the Company and, in the absence of unforeseen circumstances, aims to continue its progressive dividend policy.
The Company is able to deploy gearing, which over time is expected to enhance performance provided that the cost of gearing is less than the performance delivered by the Company's equity portfolio. The Board has set the current tactical level of gearing at 5% of net assets, with a permitted range around this level of plus or minus 5%, meaning that gearing can vary between 0% and 10%. During the period the Board decided to add additional gearing to the portfolio, drawing down US\$40 million from the revolving credit facility. In total the tactical level of gearing of the Company increased from 2.8% at year-end 2024 to 4.9% at the end of June. The overall effect of gearing during the first half of the year was to add 50bp to the return of the Company's portfolio.
The Board believes it is prudent for its gearing capacity to be funded from a mix of sources, including short- and longer-term tenors, and fixed and floating rate borrowings. The Company now has in place an £85 million revolving credit facility (with an additional £15 million accordion) with Industrial and Commercial Bank of China Limited, London Branch. This replaces the £80 million revolving credit facility (with an additional £20 million accordion) with Mizuho Bank Ltd that expired in early August 2025. It also has in issue a combined total of US\$100 million unsecured loan notes issued via private placements, US\$65 million of which are repayable in February 2031 and carry a fixed interest rate of 2.55% per annum. The remaining US\$35 million of loan notes mature in October 2032 and carry a fixed interest rate of 2.32%.
There have been no changes to the Board over the six-month review period. The Board continues to carefully manage its succession planning and remains committed to maintaining a diverse and experienced team to guide the Company's strategic direction.

The Company delivers email updates with regular news and views, as well as the latest performance. If you have not already signed up to receive these communications and you wish to do so, you can opt in via https://web.gim.jpmorgan.com/emea\_investment\_trust\_subscription/welcome?targetFund=JAM or by scanning the QR code on this page.
It is customary when commentating upon financial markets to state that the outlook remains uncertain. At present I would draw attention to the escalating number of conflicts around the world, to the fracturing of politics and the rise of more extreme parties in many countries, and to diminishing global cooperation being replaced by fiercer competition between countries. In short, it does appear that we really are in a period which is indeed very uncertain. However, North American companies and their management teams have a long track record of quickly adapting to whatever circumstances confront them, resulting in improved profitability and earnings per share. In addition, US businesses
appear to adopt new technologies more quickly than others, driving efficiencies within companies and hence sharpening their competitive edge relative to their global competition. The Board has no reason to doubt that these dynamics will not continue to prevail. The Manager remains confident that it can still identify attractive investment opportunities throughout the North American market and this fact combined with the continued dynamism of US business gives the Board confidence that the Company should continue to provide opportunities for attractive returns over the medium term.
Robert Talbut
Chair 13th August 2025
Image: Philadelphia Skyline, US
The first half of 2025 was a rollercoaster for US markets, with significant ups and downs, driven by bouts of optimism and unexpected challenges. Despite these concerns, markets demonstrated resilience and reached new all-time highs by mid-year. The S&P 500 posted a +6.2% return in US dollar terms, although it declined by –3.0% in sterling terms due to the US dollar's worst first-half performance since 1973.
As 2025 started, markets were buoyed by expectations of pro-growth policies from the new administration, which fuelled a surge in optimism. However, worries about cracks in the AI growth narrative, the threat to economic activity posed by US tariffs and geopolitical tensions soon emerged, adversely impacting global markets, and causing a growth scare that culminated in a pronounced market sell-off in April.
'Big Tech', particularly the so-called 'Magnificent 7', fell into bear market territory, significantly contributing to the downturn. Meanwhile, Treasuries rallied, although 10-year yields remained sensitive to fluctuations in the economic data. Investors also began to fret about stagflation, as the US Federal Reserve's economic projections indicated upward revisions in both the unemployment rate and core inflation to 4.4% and 2.8%, respectively, by the end of 2025.
Despite these setbacks, US equities showed resilience as the year progressed with investor fears of worst-case scenarios diminishing. An easing in trade tensions, combined with resilient employment and corporate earnings reports, and persistently tame inflation data, helped restore investor confidence. The S&P saw the fastest ever rebound from a drawdown of more than 15%, although the recovery was not universal as only some members of the Magnificent 7, Meta Platforms, Microsoft, and NVIDIA outperformed, while other names lagged. As the sectors expected to be beneficiaries of AI broadened, the industrials sector emerged as the top performer so far this year, rising by 12% in the review period, closely followed by communication services (+11%) and financial stocks (+9%). Consumer discretionary was the worst-performing sector, declining by 4%, and health care also ended in negative territory, declining by 1%.
The S&P 500, which is predominantly large-cap stocks, outshone the small-cap Russell 2000 Index, which experienced a –1.8% decline in US dollar terms. In terms of style, both value and growth achieved comparable returns.

Felise Agranoff Portfolio Manager

Jack Caffrey Portfolio Manager

Eric Ghernati Portfolio Manager

Graham Spence Portfolio Manager
The following charts provide an overview of the returns of different investment styles in the US market during the six-month period through the end of June, as well as the sector performance of the S&P 500 during that period.
| YID 2025 | Value | Blend | Growth |
|---|---|---|---|
| Large | 6.0% | 6.2% | 6.1% |
| Mid | 3.1% | 4.8% | 9.8% |
| Small | =3.2% | =1.8% | -0.5% |

The Company's net asset value declined by 4.6% on a total return basis (in GBP terms) in the first half of 2025, lagging the 3.0% drop in the S&P 500 Index. Both the large cap and small cap allocations detracted from relative performance during the period, with the Company's small cap allocation detracting the most. The overall allocation to the small cap portfolio was maintained at less than 6% over the period and stood at 5.5% at the end of June. Gearing positively impacted the portfolio performance, as shown in the table.
We remain dedicated to owning high-quality businesses with durable competitive advantages. Our concentrated bottom-up stock selection process has led to several deviations from the benchmark at both the stock and sector levels. The information technology sector remains our largest sectoral weighting in absolute terms, although it is also our largest underweight. We have modestly added to our exposure to selected software and semiconductor companies, where we see strong or rising demand.
Notably, consumer discretionary is our largest sectoral overweight. During the six-month review period, we increased our exposure by reintroducing Tesla. Overall, within the sector, we strive to maintain a balanced exposure between secular growth companies and those with less cyclicality and more defensive business models, such as globally recognised brands, with capital-light operations.
Financials represent the next largest sectoral overweight. Our strategy remains diversified, prioritising names with strong operations and the ability to adapt to evolving market dynamics. Capital One Financial is one example. The sector's relative valuations are attractive, and we are particularly interested in businesses with the potential to disrupt traditional payments systems. We are also
optimistic about companies focused on capital markets activity, as these are being supported by robust trading volumes, sporadic volatility and a potential easing in capital requirements by the new administration. We continue to hold the same names in this sector as we did at the start of the year.
For the six-month period ended 30th June 2025
| % | % | |
|---|---|---|
| Contributions to total returns | ||
| Net asset value (debt at fair value) total return | ||
| in sterling termsAPM | –4.6 | |
| Benchmark total return (in sterling terms) | –3.0 | |
| Excess return | –1.6 | |
| Combined Portfolio return in US dollar terms1 | 4.7 | |
| Benchmark total return in US dollar terms | 6.1 | |
| Combined Portfolio relative return in US dollar terms | –1.4 | |
| Large & Small Cap Portfolio contribution2 : |
||
| Large Cap Portfolio in US dollar terms | –0.6 | |
| Small Cap Portfolio in US dollar terms | –0.8 | |
| Combined Portfolio relative return in US dollar terms | –1.4 | |
| Contributions to return | ||
| Equity portfolio (ex-cash and gearing) in US dollar terms | –1.9 | |
| Cash and gearing impact in US dollar terms3 | 0.5 | |
| Combined Portfolio relative return in US dollar terms | –1.4 | |
| Effect of foreign currency translation4 | 0.1 | |
| Combined Portfolio relative return in sterling terms | –1.3 | |
| Management fee and other expenses5 | –0.2 | |
| Finance costs5 | –0.1 | |
| Share buybacks and issuances6 | 0.1 | |
| Impact of fair valuation of debt7 | –0.1 | |
| Total excess return | –1.6 |
Source: J.P. Morgan/Morningstar.
All figures are on a total return basis. Performance attribution analyses how the Company achieved its recorded performance relative to its benchmark.
The large cap portion of the portfolio, which accounts for over 90% of the Company's assets, detracted from relative performance over the period under review as our stock selection weighed on performance.
Our stock selection in the health care and consumer staples sectors detracted the most from relative performance. Within the health care space our exposure to UnitedHealth Group was the worst performer. UnitedHealth has long been regarded as the leading managed care company, consistently enjoying a premium valuation. Last year, it appeared to be operating significantly better than its competitors in the Managed Care space. However, recent developments suggest that efforts to boost growth have led to mispricing, resulting in health care costs that are significantly higher than forecast. These issues led to a notable reduction in earnings guidance, marking the first year of expected earnings decline since 2010. A former CEO has returned to the helm, and he has indicated plans to further enhance the company's management talent. Given current related uncertainties, UnitedHealth's premium valuation may no longer be justified, and while a turnaround is possible, the timing is uncertain, so we exited our position.
Our performance in consumer staples was adversely impacted by our exposure to Estee Lauder, a cosmetics company which has been facing earnings challenges, including a decline in sales in key markets such as Asia and China. In addition, there have been recent management changes and strategic uncertainties, including the withdrawal of FY25 guidance and the announcement of a significant dividend cut, aimed at providing more financial flexibility, further exacerbated market apprehension. While the company has implemented a plan to improve margins and drive future growth, we have concerns about management's ability to execute, and exited our position.
At the security level, our underweight position in NVIDIA was one of the more significant detractors during the period, as the company's share price experienced a strong rally, outperforming the S&P 500. Although NVIDIA's platform is in high demand and its software is robust, we believe the market may not be taking full account of increasing competition, including from Broadcom, another portfolio holding, which has developed a highly customisable ASIC chip. We also have some concerns that market expectations about NVIDIA's growth potential might be overdone, so we have maintained a below-index weighting to this name.
While the large cap portfolio faced several detrimental influences, there were plenty of bright spots, including strong stock selection in the information technology (IT) and financial sectors. In the IT sector, our decision to maintain an underweight position in Apple made a positive contribution to performance. This stock faced downward pressure due to concerns about the impact of US tariffs, and uncertainties regarding potential regulatory impact on its services business. The company is also experiencing ongoing challenges integrating AI into its products.
Capital One Financial, a provider of financial products and services, was a top contributor in the financial space, thanks in part to positive investor sentiment regarding the sector. The market is also positive about the benefits of Capital One's acquisition of Discover Financial Services. This deal should enhance Capital One's banking and payments platform, while also delivering both cost savings and revenue growth. Furthermore, the company's management team has a track record of successfully executing large investments, including in the business's technological transformation and its national banking strategy. This bodes well for future growth and we remain overweight this name.
Another significant contributor during the period was our underweight position in Tesla. We have previously owned this stock and know the company well. We had closed our position in January 2024 as demand for electric vehicles (EV) stalled. The stock has since faced pressure due to various investor concerns, both real and perceived. We capitalised on the sell-off by reintroducing Tesla to our portfolio. Although demand for EVs remains tentative, we are increasingly confident in the company's autonomous driving technology, which we believe is approaching commercial viability,
and we see potential for autonomous driving to enhance Tesla's brand perception and eventually reignite demand for its vehicles. This transition is in its early stages, so the portfolio remains underweight, but we anticipate that autonomous driving will significantly improve Tesla's margins over time, and our long-term investment horizon allows us to be patient while these expectations play out, especially as we took the opportunity to re-purchase the stock at an attractive level.
Over the period, the most significant portfolio shifts have occurred in the health care space, as we exited three longstanding positions due to changing fundamentals. In addition to the sale of UnitedHealth Group, already discussed, we also closed positions in Regeneron Pharmaceuticals and Eli Lilly. Regeneron Pharmaceuticals is currently navigating a tough commercial landscape, including increasing competitive pressures on its flagship product, Eylea, for the treatment of eye disease, which are raising doubts about the company's ability to maintain its market leadership in this segment. In addition, there are emerging concerns regarding the life cycle of Dupixent, used in the treatment of severe inflammatory conditions, as well as Regeneron's overall drug pipeline, which has not developed at a pace sufficient to offset diminishing demand for Eylea and Dupixent. Eli Lilly's stock dropped sharply following its latest earnings report on concerns over pricing dynamics in the weight loss drugs market. In response to these challenges, we sold our holdings in all three names. We added one new health care name – Johnson & Johnson. This large cap pharmaceutical and medical technology business trades at a discount to its peers, while offering a premium dividend and attractive dividend yield, with higher returns on equity and invested capital.
We also added exposure to industrials, with the addition of 3M, a tech services conglomerate, where we have gained confidence in the company's operational turnaround. Earlier this year, the incoming CEO highlighted new and increasingly granular plans to reinvigorate growth and improve operating performance. Additionally, 3M has strengthened its balance sheet and the management of legal liabilities, to reduce risks. These developments reinforced our view that 3M's recovery is proceeding well and looks set to exceed market expectations both in timing and magnitude.
As we have mentioned previously, the large cap portfolio is divided between growth and value stocks, with the allocation allowed to vary between 60:40 and 40:60. At the end of the review period, growth stocks comprised some 56% of the large cap portfolio, with the remaining 44% invested in value stocks. This is coincidently close to the current growth/value split of the S&P 500 index.

As of 30th June 2025
Source: J.P. Morgan Asset Management. The portfolio is actively managed. Holdings, sector weights, allocations and leverage, as applicable, are subject to change at the discretion of the investment manager without notice.
The table below shows that at the end of June 2025, the large cap portfolio was trading at a 17% discount to the market on a free cash flow basis, which confirms that we are not paying a premium for good cash flow. Indeed, the discount provides a comforting valuation cushion. The portfolio is expected to deliver earnings growth of around 13% over the next 12 months, in line with the market. However, both figures are based on consensus earnings, which may be revised over time.
| Characteristics | Large Cap Portfolio | S&P 500 |
|---|---|---|
| Weighted Average Market Cap | US\$ 1,022.0 bn | US\$ 1,064.6 bn |
| Price/Earnings, 12-months forward1 | 22.9x | 21.3x |
| Price/Free Cash Flow, last 12-months | 21.9x | 26.4x |
| Price to Book Value | 4.3x | 5.0x |
| EPS Growth, 12-months forward | 12.7% | 12.8% |
| Return on Equity, last 12-months | 20.8% | 25.4% |
| Dividend Yield, current | 1.2% | 1.2% |
| Predicted Beta | 1.00 | — |
| Predicted Tracking Error | 2.72 | — |
| Number of Holdings | 39 | 500 |
| Active Share | 63% | — |
Source: Factset, J.P. Morgan Asset Management.
1 Including negatives. Data as of 30th June 2025. The portfolio is actively managed. Holdings, sector weights, allocations and leverage, as applicable, are subject to change at the discretion of the investment manager without notice.
A Glossary of Terms is provided on page 32.
As mentioned above, the small cap portfolio negatively impacted returns over the review period, as it underperformed the S&P 500. The overall allocation to the small cap portfolio was maintained at less than 6% over the period and stood at 5.5% at the end of June. Small cap valuations continue to look compelling relative to large caps following a prolonged period during which large caps outperformed small caps. It feels as though the stage is still set for a reversal, although timing is always hard to predict.
We are optimistic about the prospects for US equities for the rest of this year and beyond. Market expectations have improved in recent months, with investors no longer focused on worst-case scenarios. And history suggests that a strong first half of the year often leads to a solid second half. Since 2000, in the 11 instances where the S&P 500 rose by at least 5% in the first half, it continued to rally in the second half, with full year gains averaging more than 19%.
In addition, the economy is demonstrating resilience, although its growth trajectory is flattening. Inflation may tick higher, due to labour market pressures and higher tariffs, but is not expected to rise significantly. The unemployment rate remains relatively stable, and consumer financial conditions are manageable. This combination suggests a stable economic environment, conducive to further, albeit modest, growth. Our confidence in the market's potential is further underpinned by expectations of robust earnings growth – our analysts predict S&P 500 earnings will increase by 8% in 2025 and 13% in 2026.
While we are encouraged by these signs of improving market fundamentals, we remain vigilant about potential risks that could spark volatility. These include ongoing geopolitical tensions and continuing shifts in US trade, regulatory, and fiscal policies.
Our focus on high-quality businesses with strong competitive advantages helps to ensure stable returns during uncertain times and when market volatility rises, we aim to capitalise on it by identifying and seizing selective opportunities that align with our long-term investment goals. Our strategy is to maintain a balanced approach, leveraging our insights and expertise to navigate market complexities, while actively seeking opportunities for growth and value creation. We are confident that this approach will continue to reward shareholders with strong capital growth over time.
Felise Agranoff Jack Caffrey Eric Ghernati Graham Spence Portfolio Managers 13th August 2025
| 30th June 2025 Valuation |
31st December 2024 Valuation |
||||||
|---|---|---|---|---|---|---|---|
| Company | Sector | £'000 | %1 | £'000 | %1 | ||
| Microsoft | Information Technology | 144,437 | 7.4 | 123,111 | 6.0 | ||
| Amazon.com | Consumer Discretionary | 111,759 | 5.7 | 124,491 | 6.1 | ||
| NVIDIA | Information Technology | 106,421 | 5.5 | 116,431 | 5.7 | ||
| Meta Platforms | Communication Services | 86,053 | 4.4 | 92,069 | 4.5 | ||
| Broadcom | Information Technology | 76,789 | 3.9 | 78,384 | 3.8 | ||
| Capital One Financial | Financials | 64,725 | 3.3 | 60,211 | 2.9 | ||
| Kinder Morgan | Energy | 59,765 | 3.1 | 67,890 | 3.3 | ||
| Apple | Information Technology | 58,619 | 3.0 | 76,254 | 3.7 | ||
| Loews | Financials | 56,032 | 2.9 | 55,533 | 2.7 | ||
| Berkshire Hathaway | Financials | 55,762 | 2.9 | 55,906 | 2.7 | ||
| Total | 820,362 | 42.1 |
1 Based on total investments of £1,951.9m (2024: £2,042.8m).
At 31st December 2024 the value of the ten largest equity investments amounted to £850.3 million representing 41.4% of total investments.
As at 30th June 2025
| Company | Valuation £'000 |
%1 |
|---|---|---|
| Large Companies | ||
| Microsoft | 144,437 | 7.4 |
| Amazon.com | 111,759 | 5.7 |
| NVIDIA | 106,421 | 5.5 |
| Meta Platforms | 86,053 | 4.4 |
| Broadcom | 76,789 | 3.9 |
| Capital One Financial | 64,725 | 3.3 |
| Kinder Morgan | 59,765 | 3.1 |
| Apple | 58,619 | 3.0 |
| Loews | 56,032 | 2.9 |
| Berkshire Hathaway | 55,762 | 2.9 |
| Intuit | 53,460 | 2.6 |
| Morgan Stanley | 49,218 | 2.5 |
| McDonald's | 47,354 | 2.4 |
| M&T Bank | 46,133 | 2.4 |
| Mastercard | 45,331 | 2.3 |
| HCA Healthcare | 44,736 | 2.3 |
| Quanta Services | 42,189 | 2.2 |
| Procter & Gamble | 42,116 | 2.2 |
| EOG Resources | 41,646 | 2.1 |
| Analog Devices | 41,574 | 2.1 |
| Honeywell International | 41,322 | 2.1 |
| Palo Alto Networks | 40,194 | 2.1 |
| Booking | 38,568 | 2.0 |
| Johnson & Johnson | 37,644 | 1.9 |
| NextEra Energy | 35,965 | 1.8 |
| Public Storage | 35,851 | 1.8 |
| Alphabet | 34,914 | 1.8 |
| Home Depot | 34,864 | 1.8 |
| Take-Two Interactive Software | 29,429 | 1.5 |
| Canadian Pacific Kansas City | 29,341 | 1.5 |
| Intuitive Surgical | 27,394 | 1.4 |
| 3M | 27,349 | 1.4 |
| Regency Centers | 25,916 | 1.3 |
| Martin Marietta Materials | 25,413 | 1.3 |
| Trane Technologies | 23,945 | 1.2 |
| TJX | 22,755 | 1.2 |
| Thermo Fisher Scientific | 20,803 | 1.1 |
| HubSpot | 20,647 | 1.1 |
| Tesla | 18,788 | 1.0 |
| 1,845,221 | 94.5 |
| Company | Valuation £'000 |
%1 |
|---|---|---|
| Small Companies | ||
| PennyMac Financial Services | 1,065 | 0.1 |
| Applied Industrial Technologies | 1,060 | 0.1 |
| Selective Insurance | 988 | 0.1 |
| Casella Waste Systems | 987 | 0.1 |
| AeroVironment | 983 | 0.1 |
| Fabrinet | 947 | 0.0 |
| Ingram Micro | 903 | 0.0 |
| Old National Bancorp | 888 | 0.0 |
| Group 1 Automotive | 887 | 0.0 |
| SPX Technologies | 879 | 0.0 |
| Other small companies (228 holdings) | 97,135 | 5.0 |
| 106,722 | 5.5 | |
| Total Investments (277 holdings) | 1,951,943 | 100.0 |
1 Based on total value of investments.
Large companies are generally defined as companies which have a market capitalisation of more than US\$3 billion and small companies are generally defined as companies which, at the date of investment, have a market capitalisation of less than US\$3 billion.
The full breakdown of the portfolio including all the small company holdings as at 30th June 2025 can be found on the Company's website.

| (Unaudited) Six months ended |
(Unaudited) Six months ended |
(Audited) Year ended |
|||||||
|---|---|---|---|---|---|---|---|---|---|
| 30th June 2025 | 30th June 2024 | 31st December 2024 | |||||||
| Revenue £'000 |
Capital £'000 |
£'000 | Total Revenue £'000 |
Capital £'000 |
£'000 | Total Revenue £'000 |
Capital £'000 |
Total £'000 |
|
| (Loss)/gains on investments | |||||||||
| held at fair value through | |||||||||
| profit or loss | — (108,492) (108,492) | — | 290,667 | 290,667 | — | 459,406 | 459,406 | ||
| Net foreign currency | |||||||||
| gains/(losses) | — | 6,206 | 6,206 | — | (798) | (798) | — | (743) | (743) |
| Income from investments | 12,473 | 5 | 12,478 | 11,281 | — | 11,281 | 23,579 | 55 | 23,634 |
| Interest receivable and similar | |||||||||
| income | 531 | — | 531 | 750 | — | 750 | 1,352 | — | 1,352 |
| Gross return/(loss) | 13,004 (102,281) | (89,277) | 12,031 | 289,869 | 301,900 | 24,931 | 458,718 | 483,649 | |
| Management fee | (551) | (2,203) | (2,754) | (499) | (1,995) | (2,494) | (1,041) | (4,164) | (5,205) |
| Other administrative expenses | (448) | — | (448) | (619) | — | (619) | (1,139) | — | (1,139) |
| Net return/(loss) before finance | |||||||||
| costs and taxation | 12,005 (104,484) | (92,479) | 10,913 | 287,874 | 298,787 | 22,751 | 454,554 | 477,305 | |
| Finance costs | (309) | (1,232) | (1,541) | (236) | (939) | (1,175) | (494) | (1,970) | (2,464) |
| Net return/(loss) before taxation | 11,696 (105,716) | (94,020) | 10,677 | 286,935 | 297,612 | 22,257 | 452,584 | 474,841 | |
| Taxation | (1,843) | (7) | (1,850) | (1,212) | (70) | (1,282) | (3,024) | — | (3,024) |
| Net return/(loss) after taxation | 9,853 (105,723) | (95,870) | 9,465 | 286,865 | 296,330 | 19,233 | 452,584 | 471,817 | |
| Return/(loss) per share (note 3) | 5.50p | (59.01)p | (53.51)p | 5.18p | 156.93p | 162.11p | 10.59p | 249.22p | 259.81p |
An interim dividend of 2.75p (2024: 2.75p) per share has been declared in respect of the six months ended 30th June 2025, amounting to £4,870,000 (2024: £5,003,000).
All revenue and capital items in the above statement derive from continuing operations. The return/(loss) per share represents the profit/(loss) per share for the period and also the total comprehensive income per share.
The 'Total' column of this statement is the profit and loss account of the Company and the 'Revenue' and 'Capital' columns represent supplementary information prepared under guidance issued by the Association of Investment Companies.
| Called up | Capital | |||||
|---|---|---|---|---|---|---|
| share | Share redemption | Capital | Revenue | |||
| capital | premium | reserve | reserves1 | reserve1 | Total | |
| £'000 | £'000 | £'000 | £'000 | £'000 | £'000 | |
| Six months ended 30th June 2025 (Unaudited) | ||||||
| At 31st December 2024 | 14,082 | 159,821 | 8,151 | 1,769,497 | 36,294 | 1,987,845 |
| Repurchase of shares into Treasury | — | — | — | (33,439) | — | (33,439) |
| Issue of shares from Treasury | — | 9,925 | — | 6,550 | — | 16,475 |
| Net (loss)/return after taxation | — | — | — | (105,723) | 9,853 | (95,870) |
| Dividends paid in the period (note 4) | — | — | — | — | (14,768) | (14,768) |
| At 30th June 2025 | 14,082 | 169,746 | 8,151 | 1,636,885 | 31,379 | 1,860,243 |
| Six months ended 30th June 2024 (Unaudited) | ||||||
| At 31st December 2023 | 14,082 | 151,850 | 8,151 | 1,358,329 | 31,587 | 1,563,999 |
| Repurchase of shares into Treasury | — | — | — | (13,910) | — | (13,910) |
| Issue of shares from Treasury | — | 4,443 | — | 3,715 | — | 8,158 |
| Proceeds from share forfeiture2 | — | — | — | 731 | — | 731 |
| Proceeds from forfeiture of unclaimed dividends2 (note 4) |
— | — | — | — | 71 | 71 |
| Net return after taxation | — | — | — | 286,865 | 9,465 | 296,330 |
| Dividends paid in the period (note 4) | — | — | — | — | (9,595) | (9,595) |
| At 30th June 2024 | 14,082 | 156,293 | 8,151 | 1,635,730 | 31,528 | 1,845,784 |
| Year ended 31st December 2024 (Audited) | ||||||
| At 31st December 2023 | 14,082 | 151,850 | 8,151 | 1,358,329 | 31,587 | 1,563,999 |
| Repurchase of shares into Treasury | — | — | — | (48,069) | — | (48,069) |
| Issue of shares from Treasury | — | 7,971 | — | 5,922 | — | 13,893 |
| Proceeds from share forfeiture2 | — | — | — | 731 | — | 731 |
| Proceeds from forfeiture of unclaimed dividends2 (note 4) |
— | — | — | — | 71 | 71 |
| Net return after taxation | — | — | — | 452,584 | 19,233 | 471,817 |
| Dividends paid in the year (note 4) | — | — | — | — | (14,597) | (14,597) |
| At 31st December 2024 | 14,082 | 159,821 | 8,151 | 1,769,497 | 36,294 | 1,987,845 |
1 These reserves form the distributable reserves of the Company and may be used to fund distributions to investors.
2 During 2024, the Company undertook an Asset Reunification Program to reunite inactive shareholders with their shares and unclaimed dividends. In accordance with the Company's Articles of Association, the Company exercised its right to forfeit the shares belonging to untraced shareholders for a period of 12 years or more. These shares were sold in the open market and the net proceeds returned to the Company. In addition, any unclaimed dividends older than 12 years from the date of payment of such dividend were forfeited and returned to the Company.
| (Unaudited) | (Unaudited) | (Audited) | |
|---|---|---|---|
| At | At | At | |
| 30th June 2025 |
30th June 20241 |
31st December 2024 |
|
| £'000 | £'000 | £'000 | |
| Fixed assets | |||
| Investments held at fair value through profit or loss | 1,951,943 | 1,925,506 | 2,042,755 |
| Current assets | |||
| Debtors | 582 | 4,245 | 600 |
| Current asset investments1 | 10,117 | 15,423 | 24,926 |
| Cash at bank1 | 430 | 12 | 112 |
| 11,129 | 19,680 | 25,638 | |
| Current liabilities | |||
| Creditors: amounts falling due within one year | (30,083) | (4,760) | (971) |
| Net current (liabilities)/assets | (18,954) | 14,920 | 24,667 |
| Total assets less current liabilities | 1,932,989 | 1,940,426 | 2,067,422 |
| Creditors: amounts falling due after more than one year | (72,746) | (94,642) | (79,577) |
| Net assets | 1,860,243 | 1,845,784 | 1,987,845 |
| Capital and reserves | |||
| Called up share capital | 14,082 | 14,082 | 14,082 |
| Share premium | 169,746 | 156,293 | 159,821 |
| Capital redemption reserve | 8,151 | 8,151 | 8,151 |
| Capital reserves | 1,636,885 | 1,635,730 | 1,769,497 |
| Revenue reserve | 31,379 | 31,528 | 36,294 |
| Total shareholders' funds | 1,860,243 | 1,845,784 | 1,987,845 |
| Net asset value per share (note 5) | 1,050.4p | 1,014.2p | 1,109.9p |
1 As at 30th June 2024, the 'Cash and cash equivalents' line item in the Statement of Financial Position has been revised to 'Cash at bank' and 'Current asset investments'. This revision separately reports the £15,423,000 investment in the JPMorgan USD Liquidity Fund as 'Current asset investments' and £12,000 as 'Cash at bank', in accordance with the statutory format required by the Companies Act 2006. This adjustment does not affect any other line items in the Statement of Financial Position or the total current assets.
The financial statements on pages 22 to 25 were approved and authorised for issue by the Directors on 13th August 2025 and were signed on their behalf by:
Director
The notes on pages 26 to 28 form an integral part of these financial statements.
Company registration number: 15543.
| (Unaudited) | (Unaudited) | (Audited) | |
|---|---|---|---|
| Six months | Six months | Year | |
| ended | ended | ended | |
| 30th June | 30th June | 31st December | |
| 2025 | 2024 | 2024 | |
| £'000 | £'000 | £'000 | |
| Cash flows from operating activities | |||
| Net (loss)/return before finance costs and taxation | (92,479) | 298,787 | 477,305 |
| Adjustment for: | |||
| Net losses/(gains) on investments held at fair value through profit or loss |
108,492 | (290,667) | (459,406) |
| Net foreign currency exchange (gains)/losses | (6,206) | 798 | 743 |
| Dividend income | (12,478) | (11,281) | (23,634) |
| Interest income | (531) | (750) | (1,352) |
| Scrip dividends received as income | (5) | — | — |
| Realised foreign currency exchange losses on transactions | (320) | (337) | (292) |
| Realised foreign currency exchange losses on JPMorgan USD Liquidity Fund |
(1,335) | (335) | (623) |
| (Increase)/decrease in accrued income and other debtors | (47) | — | 31 |
| (Decrease)/increase in accrued expenses | (174) | (11) | 41 |
| Net cash outflow from operations before dividends, | |||
| interest and taxation | (5,083) | (3,796) | (7,187) |
| Dividends received | 12,542 | 11,263 | 23,593 |
| Interest received | 531 | 826 | 1,481 |
| Overseas withholding tax paid | (1,849) | (1,300) | (3,003) |
| Net cash inflow from operating activities | 6,141 | 6,993 | 14,884 |
| Purchases of investments | (357,807) | (321,362) | (570,659) |
| Sales of investments | 340,152 | 293,680 | 595,515 |
| Net cash (outflow)/inflow from investing activities | (17,655) | (27,682) | 24,856 |
| Dividends paid | (14,768) | (9,595) | (14,597) |
| Proceeds from forfeiture of unclaimed dividends | — | 71 | 71 |
| Issue of shares from Treasury | 16,475 | 8,158 | 13,893 |
| Repurchase of shares into Treasury | (33,439) | (12,622) | (48,069) |
| Proceeds from share forfeiture | — | 731 | 731 |
| Repayment of bank loan | — | — | (15,205) |
| Drawdown of bank loan | 30,806 | 15,790 | 15,790 |
| Loan interest paid | (475) | (208) | (583) |
| Private placement interest paid | (971) | (975) | (1,925) |
| Net cash (outflow)/inflow from financing activities | (2,372) | 1,350 | (49,894) |
| Decrease in cash and cash equivalents | (13,886) | (19,339) | (10,154) |
| Cash and cash equivalents at start of period/year | 25,038 | 34,207 | 34,207 |
| Foreign currency exchange movements | (605) | 567 | 985 |
| Cash and cash equivalents at end of period/year | 10,547 | 15,435 | 25,038 |
| Cash and cash equivalents consist of: | |||
| Cash at bank | 430 | 12 | 112 |
| Current asset investments in JPMorgan USD Liquidity Fund | 10,117 | 15,423 | 24,926 |
| Total | 10,547 | 15,435 | 25,038 |
For the six months ended 30th June 2025
The information contained within the condensed financial statements in this half year report has not been audited or reviewed by the Company's auditors.
The figures and financial information for the year ended 31st December 2024 are extracted from the latest published financial statements of the Company and do not constitute statutory accounts for that year. Those financial statements have been delivered to the Registrar of Companies including the report of the auditor which was unqualified and did not contain a statement under either section 498(2) or 498(3) of the Companies Act 2006.
The condensed financial statements are prepared under the historical cost convention, modified to include fixed asset investments at fair value, in accordance with the Companies Act 2006, United Kingdom Generally Accepted Accounting Practice ('UK GAAP'), including FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and with the Statement of Recommended Practice 'Financial Statements of Investment Trust Companies and Venture Capital Trusts' (the revised 'SORP') issued by the Association of Investment Companies in July 2022.
FRS 104, 'Interim Financial Reporting', issued by the Financial Reporting Council ('FRC') in March 2015 has been applied in preparing this condensed set of financial statements for the six months ended 30th June 2025.
All of the Company's operations are of a continuing nature.
The accounting policies applied to this condensed set of financial statements are consistent with those applied in the financial statements for the year ended 31st December 2024.
| (Unaudited) | (Unaudited) | (Audited) | |
|---|---|---|---|
| Six months ended | Six months ended | Year ended | |
| 30th June | 30th June | 31st December | |
| 2025 | 2024 | 2024 | |
| £'000 | £'000 | £'000 | |
| (Loss)/return per share is based on the following: | |||
| Revenue return | 9,853 | 9,465 | 19,233 |
| Capital (loss)/return | (105,723) | 286,865 | 452,584 |
| Total (loss)/return | (95,870) | 296,330 | 471,817 |
| Weighted average number of shares in issue | 179,168,654 | 182,799,838 | 181,599,757 |
| Revenue return per share | 5.50p | 5.18p | 10.59p |
| Capital (loss)/return per share | (59.01)p | 156.93p | 249.22p |
| Total (loss)/return per share | (53.51)p | 162.11p | 259.81p |
| (Unaudited) Six months ended 30th June 2025 |
(Unaudited) Six months ended 30th June 2024 |
(Audited) Year ended 31st December 2024 |
||||
|---|---|---|---|---|---|---|
| Pence | £'000 | Pence | £'000 | Pence | £'000 | |
| Dividend paid | ||||||
| Final dividend in respect of prior year | 8.25 | 14,768 | 5.25 | 9,595 | 5.25 | 9,594 |
| Interim dividend in respect of the six months | — | — | — | — | 2.75 | 5,003 |
| Total dividends paid | 8.25 | 14,768 | 5.25 | 9,595 | 8.00 | 14,597 |
| Proceeds from forfeiture of unclaimed dividends1 | — | — | — | (71) | — | (71) |
| Net dividend | 8.25 | 14,768 | 5.25 | 9,524 | 8.00 | 14,526 |
1 During 2024, the Company undertook an Asset Reunification Program to reunite inactive shareholders with their shares and unclaimed dividends. In accordance with the Company's Articles of Association, the Company exercised its right to forfeit the shares belonging to untraced shareholders for a period of 12 years or more. These shares were sold in the open market and the net proceeds returned to the Company. In addition, any unclaimed dividends older than 12 years from the date of payment of such dividend were forfeited and returned to the Company.
All dividends paid in the period/year have been funded from the revenue reserve.
An interim dividend of 2.75p (2024: 2.75p) per share has been declared in respect of the six months ended 30th June 2025, amounting to £4,870,000 (2024: £5,003,000).
The net asset value per Ordinary share and the net asset value attributable to the Ordinary shares at the period/year end are shown below. These were calculated using 177,106,660 (30th June 2024: 182,002,868; 31st December 2024: 179,095,954) Ordinary shares in issue at the period/year end (excluding Treasury shares).
| (Unaudited) | (Unaudited) | (Audited) | ||||
|---|---|---|---|---|---|---|
| Six months ended 30th June 2025 Net asset value attributable |
Six months ended 30th June 2024 Net asset value attributable |
Year ended 31st December 2024 Net asset value attributable |
||||
| £'000 | pence | £'000 | pence | £'000 | pence | |
| Net asset value - debt at par value | 1,860,243 | 1,050.4 | 1,845,784 | 1,014.2 | 1,987,845 | 1,109.9 |
| Add: amortised cost of US\$65 million 2.55% Private | ||||||
| Placement Feb 2031 | 47,239 | 26.6 | 51,174 | 28.1 | 51,670 | 28.9 |
| Less: fair value of US\$65 million 2.55% Private | ||||||
| Placement Feb 2031 | (43,384) | (24.5) | (45,125) | (24.8) | (45,875) | (25.6) |
| Add: amortised cost of US\$35 million 2.32% Private | ||||||
| Placement Oct 2032 | 25,507 | 14.4 | 27,646 | 15.2 | 27,907 | 15.6 |
| Less: fair value of US\$35 million 2.32% Private | ||||||
| Placement Oct 2032 | (22,194) | (12.5) | (22,903) | (12.6) | (23,396) | (13.1) |
| Net asset value - debt at fair value | 1,867,411 | 1,054.4 | 1,856,576 | 1,020.1 | 1,998,151 | 1,115.7 |
The fair value hierarchy analysis for financial instruments held at fair value at the period end is as follows:
| (Unaudited) | (Unaudited) | (Audited) | ||||
|---|---|---|---|---|---|---|
| Six months ended 30th June 2025 |
Six months ended 30th June 2024 |
Year ended | ||||
| 31st December 2024 | ||||||
| Assets | Liabilities | Assets | Liabilities | Assets | Liabilities | |
| £'000 | £'000 | £'000 | £'000 | £'000 | £'000 | |
| Level 1 | 1,951,943 | — | 1,925,506 | — | 2,042,755 | — |
| Total value of investments | 1,951,943 | — | 1,925,506 | — | 2,042,755 | — |
| Foreign | |||||
|---|---|---|---|---|---|
| As at | currency | Other | As at | ||
| 31st December | exchange | non-cash | 30th June | ||
| 2024 | Cash flows | movements | charges | 2025 | |
| £'000 | £'000 | £'000 | £'000 | £'000 | |
| Cash and cash equivalents | |||||
| Cash at bank | 112 | 318 | — | — | 430 |
| Current asset investments1 | 24,926 | (14,204) | (605) | — | 10,117 |
| 25,038 | (13,886) | (605) | — | 10,547 | |
| Borrowings | |||||
| Debt due after one year | – | (30,806) | 1,616 | — | (29,190) |
| Private placements due after one year | (79,577) | — | 6,850 | (19) | (72,746) |
| (79,577) | (30,806) | 8,466 | (19) | (101,936) | |
| Net debt | (54,539) | (44,692) | 7,861 | (19) | (91,389) |
1 JPMorgan USD Liquidity Fund, money market fund.
Other non-cash charges relate to an amortisation adjustment on borrowings.

The Company is required to make the following disclosures in its half year report.
The principal risks and uncertainties faced by the Company fall into the following broad categories:
This includes risks such as Investment Strategy and Process, Investment Team, Market Risk, Technological Change, Rating Volatility and Corporate Activity Risk and Integration of ESG Factors into the Investment Process.
This includes risks relating to Operational, Resilience, Controls and Security along with Accounting, Legal and Regulatory risks.
This includes risks relating to Geopolitical, Artificial Intelligence, Climate Change, Widespread Social and Economic Disruption along with Legislative and Regulatory Changes.
Whilst the Board has not identified any new emerging risks at the time of publication of this report, it has noted the continued heightened level and evolving nature of the Geopolitical risks facing the Company and is monitoring these accordingly.
Information on each of these risks is given in the Strategic Report within the Annual Report and Financial Statements for the year ended 31st December 2024. In the view of the Board, these principal risks and uncertainties are as much applicable to the remaining six months of the financial year as they were to the six months under review.
During the first six months of the current financial year, no transactions with related parties have taken place which have materially affected the financial position or the performance of the Company.
In accordance with The Financial Reporting Council's guidance on going concern and liquidity risk, the Directors have undertaken a rigorous review of the Company's ability to continue as a going concern. The Board has, in particular, considered the impact of market volatility from the ongoing conflicts between Ukraine and Russia and in the Middle East, and does not believe the Company's going concern status is affected. The Company's assets, the vast majority of which are investments in quoted securities which are readily realisable, exceed its liabilities significantly under all stress test scenarios reviewed by the Board. Gearing levels and compliance with
borrowing covenants are reviewed by the Board on a regular basis. Furthermore, the Directors are satisfied that the Company's key third party service providers have in place appropriate business continuity plans to ensure their operational resilience and the performance of these service providers is reviewed at least annually by the Management Engagement Committee.
Accordingly, having assessed the principal and emerging risks and other matters, the Directors believe that there are no material uncertainties pertaining to the Company that would prevent its ability to continue in such operational existence for at least 12 months from the date of the approval of this half yearly financial report.
The Board of Directors confirms that, to the best of its knowledge:
In order to provide these confirmations, and in preparing these financial statements, the Directors are required to:
and the Directors confirm that they have done so.
For and on behalf of the Board
Robert Talbut
Chair 13th August 2025

Active Share – This measures the percentage of a portfolio that differs from a benchmark index. A higher active share indicates that the portfolio is more actively managed and deviates more from the index. It is calculated by summing the absolute differences between the portfolio and benchmark weights for each security, then dividing by two.
Benchmark total return – Total return on the benchmark, on a closing-market value to closing-market value basis, assuming that all dividends received were reinvested, without transaction costs, in the shares of the underlying companies at the time the shares were quoted ex-dividend.
The benchmark is a recognised index of stocks which should not be taken as wholly representative of the Company's investment universe. The Company's investment strategy does not follow or 'track' this index and consequently, there may be some divergence between the Company's performance and that of the benchmark.
EPS Growth, 12-month forward – Refers to the projected growth rate of a company's earnings per share (EPS) over the next 12 months. This metric is used by investors and analysts to estimate how much a company's earnings are expected to increase in the future.
Predicted Beta – is a measure of a stock's or portfolio's expected sensitivity to movements in the overall market. It is a forward-looking estimate of how much the asset's returns are expected to change in response to changes in the market index.
Predicted Tracking Error – is a measure of the expected deviation of a portfolio's returns from its benchmark index. It quantifies the risk of a portfolio not following the benchmark's performance. Low tracking error indicates that the portfolio's returns are expected to closely follow the
benchmark. High tracking error suggests that the portfolio's returns may deviate significantly from the benchmark, indicating active management or different risk exposures.
Price/Earnings, 12-month forward – This is a financial metric that measures the price of a company's stock relative to its expected earnings over the next 12 months. A higher forward P/E ratio might indicate that investors expect higher growth in the future, while a lower ratio could suggest lower growth expectations or that the stock is undervalued.
Price/Free Cash Flow, last 12-months – The Price/Free Cash Flow ratio is a financial metric used to evaluate the valuation of a company. It compares the company's market price per share to its free cash flow per share over the last 12 months. This ratio helps investors understand how much they are paying for a company's free cash flow, which is the cash generated by the company that is available for distribution to shareholders, reinvestment, or debt repayment. A lower ratio may indicate that a company is undervalued or generating strong free cash flow relative to its market price, while a higher ratio might suggest overvaluation or weaker free cash flow generation.
Return on Equity, last 12-months – is a financial metric used to assess the profitability of a company in relation to its equity. When applied to a portfolio of investments, ROE can help evaluate how effectively the investments are generating returns relative to the equity invested in them.
Weighted Average Market Cap – Is a measure used to determine the average market capitalisation of a portfolio or index, where each component's market cap is weighted according to its proportion in the portfolio or index. This metric provides insight into the size characteristics of the investments within the portfolio or index.
Alternative Performance Measures (APMs) are numerical measures of current, historical or future financial performance, financial position or cash flow that are not GAAP measures. APMs are intended to supplement the information in the financial statements, providing useful industry-specific information that can assist shareholders to better understand the performance of the Company.
Where a measure is labelled as an APM, a definition and reconciliation to a GAAP measure is set out below.
Total return on share price, on a last traded price to last traded price basis, assuming that all dividends received were reinvested, without transaction costs, into the shares of the Company at the time the shares were quoted ex-dividend.
| Six months ended | |||
|---|---|---|---|
| Total return calculation | Page | 30th June 2025 | |
| Opening share price as at 31st December 2024 (p) | 7 | 1,130.0 | (a) |
| Closing share price as at 30th June 2025 (p) | 7 | 1,022.0 | (b) |
| Total dividend adjustment factor1 | 1.009116 | (c) | |
| Adjusted closing share price (p) (d = b x c) | 1,031.3 | (d) | |
| Total return on share price (e = (d/a) – 1) | (8.7)% | (e) |
1 The dividend adjustment factor is calculated on the assumption that the dividends paid out by the Company are reinvested into the shares of the Company at the last traded price quoted at the ex-dividend date.
Total return on net asset value ('NAV') per share, with debt at fair value, assuming that all dividends paid out by the Company were reinvested into shares of the Company at the NAV per share at the time the shares were quoted ex-dividend.
The Company's debt (including the private placements) is valued in the Statement of Financial Position (on page 24) at amortised cost, which is materially equivalent to the repayment value of the debt on the assumption that it is held to maturity. This is often referred to as 'Debt at Par Value'.
The current replacement or market value of the debt, which assumes it is repaid and renegotiated under current market conditions, is often referred to as the 'Debt at Fair Value'.
The difference between fair and par values of the debt is subtracted from the NAV to derive the NAV with debt at fair value. The fair value of the combined US\$100 million private placements has been calculated using discounted cash flow techniques, using the yield from similar dated treasury notes plus a margin based on the US Broad Market AA 10-15 year spread.
| Six months ended | |||
|---|---|---|---|
| Total return calculation Page |
30th June 2025 | ||
| Opening cum-income NAV per share with debt at fair value as at | |||
| 31st December 2024 (p) | 7 | 1,115.7 | (a) |
| Closing cum-income NAV per share with debt at fair value as at | |||
| 30th June 2025 (p) | 7 | 1,054.4 | (b) |
| Total dividend adjustment factor1 | 1.009224 | (c) | |
| Adjusted closing cum-income NAV per share with debt at | |||
| fair value (p) (d = b x c) | 1,064.1 | (d) | |
| Total return on net assets with debt at fair value (e = (d/a) – 1) | (4.6)% | (e) |
1 The dividend adjustment factor is calculated on the assumption that the dividends paid out by the Company are reinvested into the shares of the Company at the cum-income NAV at the ex-dividend date.
Total return on net asset value ('NAV') per share, with debt at par value, assuming that all dividends paid out by the Company were reinvested into the shares of the Company at the NAV per share at the time the shares were quoted ex-dividend.
| Six months ended | |||
|---|---|---|---|
| Total return calculation | Page | 30th June 2025 | |
| Opening cum-income NAV per share with debt at par value as at | |||
| 31st December 2024 (p) | 7 | 1,109.9 | (a) |
| Closing cum-income NAV per share with debt at par value as at | |||
| 30th June 2025 (p) | 7 | 1,050.4 | (b) |
| Total dividend adjustment factor1 | 1.009274 | (c) | |
| Adjusted closing cum-income NAV per share with debt at par value (p) (d = b x c) | 1,060.1 | (d) | |
| Total return on net assets with debt at par value (e = (d/a) – 1) | (4.5)% | (e) |
1 The dividend adjustment factor is calculated on the assumption that the dividends paid out by the Company are reinvested into the shares of the Company at the cum-income NAV at the ex-dividend date.
This is the difference between the return on net assets, with debt at fair value, and the benchmark return. For periods greater than one year, the relative return has been annualised. Annualised returns show the average yearly return, taking account for compounding over the period.
The value of the Company's net assets (total assets less total liabilities) divided by the number of ordinary shares in issue. Please see note 5 on page 27 for detailed calculations.
Gearing represents the excess amount above shareholder's funds of total investments, expressed as a percentage of the shareholders' funds. If the amount calculated is negative, this is shown as a 'net cash' position.
| Six months ended | Year ended | |||
|---|---|---|---|---|
| 30th June | 31st December | |||
| 2025 | 2024 | |||
| Gearing calculation | Page | £'000 | £'000 | |
| Investments held at fair value through profit or loss | 28 | 1,951,943 | 2,042,755 | (a) |
| Net assets | 27 | 1,860,243 | 1,987,845 | (b) |
| Gearing (c = (a/b) – 1) | 7 | 4.9% | 2.8% | (c) |
The ongoing charges represent the Company's management fee and all other operating expenses excluding finance costs payable, expressed as a percentage of the average of the daily cum-income net assets during the year and is calculated in accordance with guidance issued by the Association of Investment Companies.
The figure as at 30th June 2025 is an estimated annualised figure based on the numbers for the six months ended 30th June 2025.
| Six months ended | Year ended | |||
|---|---|---|---|---|
| 30th June | 31st December | |||
| 2025 | 2024 | |||
| Ongoing charges ratio calculation | Page | £'000 | £'000 | |
| Management Fee | 22 | 2,754 | 5,205 | |
| Other administrative expenses | 22 | 448 | 1,139 | |
| Total management fee and other administrative expenses | 3,202 | 6,344 | (a) | |
| Average daily cum-income net assets | 1,881,191 | 1,807,798 | (b) | |
| Ongoing charges ratio (c = (a/b) x 2) | 7 | 0.34% | (c) | |
| Ongoing charges ratio (d = a/b) | 0.35% | (d) |
If the share price of an investment trust is lower than the NAV per share, the shares are said to be trading at a discount. The discount is shown as a percentage of the NAV per share. The opposite of a discount is a premium. It is more common for an investment trust company's shares to trade at a discount than at a premium (see page 9).
| Six months ended | Year ended | |||
|---|---|---|---|---|
| 30th June | 31st December | |||
| Page | 2025 | 2024 | ||
| Share price (p) | 7 | 1,022.0 | 1,130.0 | (a) |
| Net asset value per share with debt at fair value (p) | 7 | 1,054.4 | 1,115.7 | (b) |
| (Discount)/premium to net asset value with debt at | ||||
| fair value (c = (a–b)/b) | 7 | (3.1)% | 1.3% | (c) |
| Six months ended | Year ended | |||
|---|---|---|---|---|
| 30th June | 31st December | |||
| Page | 2025 | 2024 | ||
| Share price (p) | 7 | 1,022.0 | 1,130.0 | (a) |
| Net asset value per share with debt at par value (p) | 7 | 1,050.4 | 1,109.9 | (b) |
| (Discount)/premium to net asset value with debt at | ||||
| par value (c = (a–b)/b) | 7 | (2.7)% | 1.8% | (c) |
You can invest in JPMorgan American Investment Trust plc through the following:
Third party providers include:
| AJ Bell Investcentre |
|---|
| Barclays Smart investor |
| Charles Stanley Direct |
| Fidelity Personal Investing |
Halifax Share Dealing Hargreaves Lansdown interactive investor
Please note this list is not exhaustive and the availability may vary depending on the provider. These are third party providers and the Company does not endorse or recommend any. Please observe each provider's privacy and cookie policies as well as their platform charges structure.
The Board encourages all of its shareholders to exercise their rights and notes that many specialist platforms provide shareholders with the ability to receive company documentation, to vote their shares and to attend general meetings, at no cost. Please refer to your investment platform for more details, or visit the Association of Investment Companies' ('AIC') website at
www.theaic.co.uk/aic/shareholder-voting-consumer-platforms for information on which platforms support these services and how to utilise them.
Professional advisers are usually able to access the products of all the companies in the market and can help you find an investment that suits your individual circumstances. An adviser will let you know the fee for their service before you go ahead. You can find an adviser at unbiased.co.uk
You may also buy investment trusts through stockbrokers, wealth managers and banks.
To familiarise yourself with the Financial Conduct Authority (FCA) adviser charging and commission rules, visit fca.org.uk

Ûèíèæ÷øñèûóèæ÷èçòģèõö Scammers usually cold call, but contact can also come by email, post, word of mouth òõä÷äöèðìñäõÒéüòøđùèåèèñòģèõèçäñ investment out of the blue, chances are it's 1
a high risk investment or a scam.
2
3
Use the FCA Warning List to check the risks of a potential investment – you can also search ÷òöèèìé÷ëèĤõðìöîñòúñ÷òåèòóèõä÷ìñêúì÷ëòø÷ our authorisation.
Get impartial advice before investing – don't use äñäçùìöèõéõòð÷ëèĤõð÷ëä÷æòñ÷äæ÷èçüòø
Yòøæäñõèóòõ÷÷ëèĤõðòõöæäð÷òøöåü contacting our Consumer Helpline on 0800 111 6768 or using our reporting form using the link below.
If you've lost money in a scam, contact Action Fraud on 0300 123 2040 or www.actionfraud.police.uk
Be ScamSmart and visit úúúéæäòõêøî¦öæäðöðäõ÷
The Company has its origins in the Alabama, New Orleans, Texas and Pacific Junction Railways Company Limited which was formed in 1881 to acquire interests in, and to undertake the completion of, three American railroads – the Vicksburg and Meridian, the Vicksburg, Shreveport and Pacific and the New Orleans and North Eastern. In 1917 the Company was reorganised, a proportion of the railroad interests were sold, and the investment powers were widened enabling its assets to be invested in several countries including the United Kingdom. To reflect the new objectives the name was changed to The Sterling Trust. The Company's investment policy reverted to North American securities in 1982 when the name was changed to The Fleming American Investment Trust plc. The name was changed to JPMorgan Fleming American Investment Trust plc in April 2002 and to its present form in 2006. JPMorgan, and its predecessor company, has been the Company's manager and secretary since 1966.
| Robert Talbut | (Chair of the Board, Nomination Committee and |
|---|---|
| Management Engagement Committee) | |
| Claire Binyon | (Chair of Audit Committee) |
| Nadia Manzoor (Senior Independent Director and Chair of | |
| Remuneration Committee) | |
| Pui Kei Yuen | (Chair of Risk Committee) |
| Colin Moore |
Company registration number: 15543 Country of registration: England and Wales London Stock Exchange number: 08456505 ISIN: GB00BKZGVH64 SEDOL Code: BKZGVH6 Bloomberg code: JAM LN LEI: 549300QNAI4XRPEB4G65
The Company's shares are listed on the London Stock Exchange. The market price is shown daily in the Financial Times and on the J.P. Morgan website at www.jpmamerican.co.uk, where the share price is updated every 15 minutes during trading hours.
www.jpmamerican.co.uk
A member of the AIC London EC2V 6ET
The Company's shares may be dealt in directly through a stockbroker or professional adviser acting on an investor's behalf.
JPMorgan Funds Limited
60 Victoria Embankment London EC4Y 0JP Telephone: 0800 20 40 20 or +44 1268 44 44 70 email: [email protected]
For company secretarial and administrative matters, please contact Divya Amin at the above address.
The Bank of New York Mellon (International) Limited 160 Queen Victoria Street London EC4V 4LA The Depositary has appointed JPMorgan Chase Bank, N.A. as the Company's custodian.
Computershare Investor Services PLC The Pavilions Bridgwater Road Bristol, BS99 6ZZ Telephone number: +44 (0) 370 707 1519
Lines open 8.30 a.m. to 5.30 p.m. Monday to Friday. Calls to the helpline will cost no more than a national rate call to a 01 or 02 number. If calling from outside of the UK, please ensure the country code is used.
Shareholders can manage their shareholding online by visiting Investor Centre at www.investorcentre.co.uk. Shareholders just require their Shareholder Reference Number ('SRN'), which can be found on any communications previously received from Computershare.
BDO LLP (Statutory Auditor) 55 Baker Street London W1U 7EU
Stifel Nicolaus Europe Limited 4th floor, 150 Cheapside,
60 Victoria Embankment London EC4Y 0JP Freephone: 0800 20 40 20 Calls from outside the UK: +44 1268 44 44 70 Website: www.jpmamerican.co.uk


Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.